Symbiotec Pharmalab IPO GMP Today
The Symbiotec Pharmalab IPO GMP is ₹270 (27.33% over the upper price band of ₹988) as of 27 Aug 2026, giving an estimated listing price of ₹1,258 per share. On a minimum application of 15 shares, that is an estimated gain of ₹4,050. GMP has risen by ₹50 since tracking began on 19 Aug.
Last updated
- Issue Price
- ₹988
- GMP
- ₹270
- GMP %
- 27.33%
- Est. listing
- ₹1,258
- Est. gain / application
- +₹4,050
Symbiotec Pharmalab IPO GMP trend
Tracked for 9 days. High ₹410 on 22 Aug, low ₹220 on 19 Aug.
Symbiotec Pharmalab IPO GMP day-wise
| Date | GMP | Change | GMP % | Est. listing | Est. gain (15 sh) |
|---|---|---|---|---|---|
| (latest) | ₹270 | -₹15 | 27.33% | ₹1,258 | +₹4,050 |
| ₹285 | -₹67 | 28.85% | ₹1,273 | +₹4,275 | |
| ₹352 | +₹17 | 35.63% | ₹1,340 | +₹5,280 | |
| ₹335 | -₹74 | 33.91% | ₹1,323 | +₹5,025 | |
| ₹409 | -₹1 | 41.40% | ₹1,397 | +₹6,135 | |
| ₹410 | +₹65 | 41.50% | ₹1,398 | +₹6,150 | |
| ₹345 | +₹45 | 34.92% | ₹1,333 | +₹5,175 | |
| ₹300 | +₹80 | 30.36% | ₹1,288 | +₹4,500 | |
| ₹220 | — | 22.27% | ₹1,208 | +₹3,300 |
Est. listing = upper price band (₹988) + GMP. Est. gain = GMP × 15 shares (1 lot, the minimum application).
Symbiotec Pharmalab IPO subscription status
| QIB | 172.03x |
|---|---|
| bNII | 82.92x |
| sNII | 55.07x |
| Retail | 12.96x |
| Total | 71.26x |
Reading the Symbiotec Pharmalab IPO GMP
The grey market premium is the price above the issue price at which Symbiotec Pharmalab IPO shares are informally traded before listing. A GMP of ₹270 on an upper band of ₹988 suggests the shares could open around ₹1,258, if grey market sentiment holds until listing day.
GMP is not set by the company, the exchanges or SEBI. It moves daily with market conditions and subscription demand. Check it together with the subscription numbers and the company's financials before applying.
Symbiotec Pharmalab IPO GMP: FAQs
- What is Symbiotec Pharmalab IPO GMP today?
- The latest grey market premium (GMP) for the Symbiotec Pharmalab IPO is ₹270 as of 27 August 2026, which is 27.33% over the upper price band of ₹988.
- What is the expected listing price of Symbiotec Pharmalab IPO?
- Based on the current GMP, the estimated listing price of Symbiotec Pharmalab IPO is ₹1,258 per share (₹988 issue price + ₹270 GMP). This is an estimate from unofficial grey market trades, not a guaranteed listing price.
- What is the lot size and minimum investment for Symbiotec Pharmalab IPO?
- The lot size is 15 shares. The minimum application is 1 lot, which costs ₹14,820 at the upper price band.
- Is IPO GMP reliable?
- GMP reflects unofficial trades before listing and changes daily with market mood and subscription demand. It is a useful sentiment indicator but often differs from the actual listing price, so use it alongside the company's financials and subscription data.
GMP is an unofficial indicator compiled from grey market sources and is not investment advice. Actual listing prices can differ significantly. Read the offer document before investing.